Compare Stocks → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AGILWNASDAQ:PEARWNASDAQ:VENAW Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGILWAgileThought$0.00$0.00▼$0.60N/AN/A27,993 shs192,300 shsPEARWPear Therapeutics$0.00$0.00▼$0.90N/AN/A67,408 shsN/AVENAWVenus Acquisition$0.50$0.44$0.01▼$0.35N/AN/A20,861 shs5 shs7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGILWAgileThought0.00%0.00%0.00%0.00%-99.67%PEARWPear Therapeutics0.00%0.00%0.00%0.00%+18.00%VENAWVenus Acquisition0.00%0.00%0.00%+400.00%+6,796.55%The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGILWAgileThoughtN/AN/AN/AN/AN/AN/AN/AN/APEARWPear TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AVENAWVenus AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGILWAgileThoughtN/AN/AN/AN/APEARWPear TherapeuticsN/AN/AN/AN/AVENAWVenus AcquisitionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGILWAgileThought$166.63MN/AN/AN/AN/AN/APEARWPear TherapeuticsN/AN/AN/AN/AN/AN/AVENAWVenus AcquisitionN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGILWAgileThoughtN/AN/A0.00N/AN/AN/AN/AN/AN/APEARWPear TherapeuticsN/AN/A0.00N/AN/AN/AN/AN/AN/AVENAWVenus AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGILWAgileThoughtN/AN/AN/AN/AN/APEARWPear TherapeuticsN/AN/AN/AN/AN/AVENAWVenus AcquisitionN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGILWAgileThoughtN/APEARWPear TherapeuticsN/AVENAWVenus AcquisitionN/AInsider OwnershipCompanyInsider OwnershipAGILWAgileThoughtN/APEARWPear TherapeuticsN/AVENAWVenus AcquisitionN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAGILWAgileThought1,416N/AN/ANot OptionablePEARWPear TherapeuticsN/AN/AN/ANot OptionableVENAWVenus AcquisitionN/AN/AN/ANot OptionableAGILW, PEARW, and VENAW HeadlinesNo headlines for this company have been tracked by MarketBeat.comCompany DescriptionsAgileThoughtNASDAQ:AGILWfrom ideation and design to scaled delivery and support, agilethought helps fortune 1000 clients transform, build and run their digital business. agilethought leverages next-generation technologies to create competitive differentiation and exceptional customer experiences for their clients. with consultants and delivery centers across north and latin america, agilethought provides scaled agile-first delivery for a variety of industries with expanding expertise across all facets of digital transformation application development, advanced data analytics (ai, ml, & iot), cloud services, ux design, devops, and automation.Pear TherapeuticsNASDAQ:PEARWVenus AcquisitionNASDAQ:VENAW Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
